{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T03:42:47Z","timestamp":1794886967870,"version":"4.9.1"},"reference-count":81,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"22","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11,20]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Atrial fibrillation (AF), the most common sustained arrhythmia, is associated with a range of symptoms, including palpitations, cognitive impairment, systemic embolism, and increased mortality. It places a significant burden on healthcare systems worldwide. Despite decades of research, the precise mechanisms underlying AF remain elusive. Current understanding suggests that factors like stretch-induced fibrosis, epicardial adipose tissue (EAT), chronic inflammation, autonomic nervous system (ANS) imbalances, and genetic mutations all play significant roles in its development. In recent years, the advent of wearable devices has revolutionized AF diagnosis, enabling timely detection and monitoring. However, balancing early diagnosis with efficient resource utilization presents new challenges for healthcare providers. AF management primarily focuses on stroke prevention and symptom alleviation. Patients at high risk of thromboembolism require anticoagulation therapy, and emerging pipeline drugs, particularly factor XI inhibitors, hold promise for achieving effective anticoagulation with reduced bleeding risks. The scope of indications for catheter ablation in AF has expanded significantly. Pulsed field ablation, as a novel energy source, shows potential for improving success rates while ensuring safety. This review integrates existing knowledge and ongoing research on AF pathophysiology and clinical management, with emphasis on diagnostic devices, next-generation anticoagulants, drugs targeting underlying mechanisms, and interventional therapies. It offers a comprehensive mosaic of AF, providing insights into its complexities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cm9.0000000000002906","type":"journal-article","created":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T23:00:08Z","timestamp":1698879608000},"page":"2668-2676","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":45,"title":["Atrial fibrillation: mechanism and clinical management"],"prefix":"10.1097","volume":"136","author":[{"given":"Zhicheng","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ligang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,11,1]]},"reference":[{"key":"R1-20250602","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"R2-20250602","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/europace\/euac237","article-title":"Global burden of atrial fibrillation\/atrial flutter and its attributable risk factors from 1990 to 2019","volume":"25","author":"Dong","year":"2023","journal-title":"Europace"},{"key":"R3-20250602","doi-asserted-by":"crossref","first-page":"20220174","DOI":"10.1098\/rstb.2022.0174","article-title":"Advances in basic and translational research in atrial fibrillation","volume":"378","author":"Hu","year":"2023","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"R4-20250602","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1161\/CIRCULATIONAHA.120.048121","article-title":"Cardiac pressure overload decreases ETV1 expression in the left atrium, contributing to atrial electrical and structural remodeling","volume":"143","author":"Yamaguchi","year":"2021","journal-title":"Circulation"},{"key":"R5-20250602","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/pace.13825","article-title":"Epicardial adipose tissue and atrial fibrillation: possible mechanisms, potential therapies, and future directions","volume":"43","author":"Zhou","year":"2020","journal-title":"Pacing Clin Electrophysiol"},{"key":"R6-20250602","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00395-020-00827-7","article-title":"Cellular and mitochondrial mechanisms of atrial fibrillation","volume":"115","author":"Mason","year":"2020","journal-title":"Basic Res Cardiol"},{"key":"R7-20250602","first-page":"1139","article-title":"The autonomic coumel triangle: a new way to define the fascinating relationship between atrial fibrillation and the autonomic nervous system","volume":"13","author":"Rebecchi","year":"2023","journal-title":"Life (Basel)"},{"key":"R8-20250602","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jama.2018.8102","article-title":"Effect of a home-based wearable continuous ECG monitoring patch on detection of undiagnosed atrial fibrillation: the mSToPS randomized clinical trial","volume":"320","author":"Steinhubl","year":"2018","journal-title":"JAMA"},{"key":"R9-20250602","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1901183","article-title":"Large-scale assessment of a smartwatch to identify atrial fibrillation","volume":"381","author":"Perez","year":"2019","journal-title":"N Engl J Med"},{"key":"R10-20250602","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.jacc.2020.01.052","article-title":"Mobile health technology to improve care for patients with atrial fibrillation","volume":"75","author":"Guo","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R11-20250602","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCRESAHA.120.316366","article-title":"Animal models of atrial fibrillation","volume":"127","author":"Sch\u00fcttler","year":"2020","journal-title":"Circ Res"},{"key":"R12-20250602","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/cvr\/cvab035","article-title":"The effects of cardiac stretch on atrial fibroblasts: analysis of the evidence and potential role in atrial fibrillation","volume":"118","author":"Li","year":"2022","journal-title":"Cardiovasc Res"},{"key":"R13-20250602","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/eurheartj\/ehz786","article-title":"Atrial fibrillation and cardiac fibrosis","volume":"41","author":"Sohns","year":"2020","journal-title":"Eur Heart J"},{"key":"R14-20250602","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/joa3.12359","article-title":"Epicardial adipose tissue affects the efficacy of left atrial posterior wall isolation for persistent atrial fibrillation","volume":"36","author":"Nakatani","year":"2020","journal-title":"J Arrhythm"},{"key":"R15-20250602","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41569-022-00679-9","article-title":"Epicardial adipose tissue in contemporary cardiology","volume":"19","author":"Iacobellis","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"R16-20250602","doi-asserted-by":"crossref","first-page":"1154824","DOI":"10.3389\/fendo.2023.1154824","article-title":"Epicardial adipocytes in the pathogenesis of atrial fibrillation: an update on basic and translational studies","volume":"14","author":"Willar","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R17-20250602","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.3390\/cells10102605","article-title":"Atrial cardiomyopathy: pathophysiology and clinical consequences","volume":"10","author":"Goette","year":"2021","journal-title":"Cells"},{"key":"R18-20250602","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s40291-020-00497-0","article-title":"Meta-analysis of transcriptomic data reveals pathophysiological modules involved with atrial fibrillation","volume":"24","author":"Haas bueno","year":"2020","journal-title":"Mol Diagn Ther"},{"key":"R19-20250602","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s12551-020-00735-z","article-title":"Insight into atrial fibrillation through analysis of the coding transcriptome in humans","volume":"12","author":"Steenman","year":"2020","journal-title":"Biophys Rev"},{"key":"R20-20250602","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/cvr\/cvab093","article-title":"Why translation from basic discoveries to clinical applications is so difficult for atrial fibrillation and possible approaches to improving it","volume":"117","author":"Nattel","year":"2021","journal-title":"Cardiovasc Res"},{"key":"R21-20250602","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.jacc.2022.03.379","article-title":"Inflammasome signaling in atrial fibrillation: JACC state-of-the-art review","volume":"79","author":"Ajoolabady","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"R22-20250602","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/CIRCULATIONAHA.118.035202","article-title":"Enhanced cardiomyocyte NLRP3 inflammasome signaling promotes atrial fibrillation","volume":"138","author":"Yao","year":"2018","journal-title":"Circulation"},{"key":"R23-20250602","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.tips.2022.04.003","article-title":"NLRP3 and pyroptosis blockers for treating inflammatory diseases","volume":"43","author":"Coll","year":"2022","journal-title":"Trends Pharmacol Sci"},{"key":"R24-20250602","doi-asserted-by":"crossref","first-page":"175091","DOI":"10.1016\/j.ejphar.2022.175091","article-title":"Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome","volume":"928","author":"Li","year":"2022","journal-title":"Eur J Pharmacol"},{"key":"R25-20250602","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/joa3.12512","article-title":"Atrial fibrillation and autonomic nervous system: a translational approach to guide therapeutic goals","volume":"37","author":"Rebecchi","year":"2021","journal-title":"J Arrhythm"},{"key":"R26-20250602","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1093\/cvr\/cvab172","article-title":"Neuroscientific therapies for atrial fibrillation","volume":"117","author":"Hanna","year":"2021","journal-title":"Cardiovasc Res"},{"key":"R27-20250602","doi-asserted-by":"crossref","first-page":"a034173","DOI":"10.1101\/cshperspect.a034173","article-title":"Vagus nerve stimulation and the cardiovascular system","volume":"10","author":"Capilupi","year":"2020","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R28-20250602","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.4022\/jafib.2405","article-title":"Role of ganglionated plexus ablation in atrial fibrillation on the basis of supporting evidence","volume":"13","author":"Hardy","year":"2020","journal-title":"J Atr Fibrillation"},{"key":"R29-20250602","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jacc.2021.12.010","article-title":"Autonomic neuromodulation for atrial fibrillation following cardiac surgery: JACC review topic of the week","volume":"79","author":"Zafeiropoulos","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"R30-20250602","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.3389\/fnins.2018.01058","article-title":"Sympathetic nervous system activation and its modulation: role in atrial fibrillation","volume":"12","author":"Carnagarin","year":"2018","journal-title":"Front Neurosci"},{"key":"R31-20250602","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/s41431-020-00784-8","article-title":"Atrial fibrillation-a complex polygenetic disease","volume":"29","author":"Andersen","year":"2021","journal-title":"Eur J Hum Genet"},{"key":"R32-20250602","first-page":"e93","article-title":"Polygenic risk scores for cardiovascular disease: a scientific statement from the American Heart Association","volume":"146","author":"O'Sullivan","year":"2022","journal-title":"Circulation"},{"key":"R33-20250602","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41572-022-00347-9","article-title":"Atrial fibrillation","volume":"8","author":"Brundel","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"R34-20250602","doi-asserted-by":"crossref","first-page":"e006274","DOI":"10.1161\/CIRCEP.118.006274","article-title":"Thirty-second gold standard definition of atrial fibrillation and its relationship with subsequent arrhythmia patterns: analysis of a large prospective device database","volume":"11","author":"Steinberg","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R35-20250602","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1161\/CIRCULATIONAHA.122.060291","article-title":"Detection of atrial fibrillation in a large population using wearable devices: the Fitbit Heart Study","volume":"146","author":"Lubitz","year":"2022","journal-title":"Circulation"},{"issue":"17","key":"R36-20250602","doi-asserted-by":"crossref","first-page":"417","DOI":"10.21037\/atm.2019.06.79","article-title":"Apple Watch, Wearables, and Heart Rhythm: where do we stand?","volume":"7","author":"Raja","year":"2019","journal-title":"Ann Transl Med"},{"key":"R37-20250602","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1055\/s-0040-1716408","article-title":"The 4S-AF scheme (stroke risk; symptoms; severity of burden; substrate): a novel approach to in-depth characterization (rather than classification) of atrial fibrillation","volume":"121","author":"Potpara","year":"2021","journal-title":"Thromb Haemost"},{"key":"R38-20250602","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"R39-20250602","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/europace\/eut395","article-title":"The European Heart Rhythm Association symptom classification for atrial fibrillation: validation and improvement through a simple modification","volume":"16","author":"Wynn","year":"2014","journal-title":"Europace"},{"key":"R40-20250602","doi-asserted-by":"crossref","first-page":"9232","DOI":"10.3390\/ijms21239232","article-title":"Galectin-3 in cardiovascular diseases","volume":"21","author":"Blanda","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R41-20250602","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/eurheartj\/ehy731","article-title":"Risk stratification for stroke in atrial fibrillation: a critique","volume":"40","author":"Killu","year":"2019","journal-title":"Eur Heart J"},{"key":"R42-20250602","doi-asserted-by":"crossref","first-page":"663","DOI":"10.7326\/M18-1177","article-title":"Reassessment of risk for stroke during follow-up of patients with atrial fibrillation","volume":"170","author":"Chao","year":"2019","journal-title":"Ann Intern Med"},{"key":"R43-20250602","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1136\/bmj.1.5392.1209","article-title":"Systemic embolism and anticoagulant prophylaxis in rheumatic heart disease","volume":"1","author":"Szekely","year":"1964","journal-title":"Br Med J"},{"key":"R44-20250602","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/CIRCULATIONAHA.121.056355","article-title":"Direct oral anticoagulants versus warfarin in patients with atrial fibrillation: patient-level network meta-analyses of randomized clinical trials with interaction testing by age and sex","volume":"145","author":"Carnicelli","year":"2022","journal-title":"Circulation"},{"key":"R45-20250602","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"R46-20250602","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1093\/ehjqcco\/qcab050","article-title":"Should oral anticoagulants still be prescribed to patients with atrial fibrillation with a single stroke risk factor but at high bleeding risk? A nationwide cohort study","volume":"8","author":"Chao","year":"2022","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"R47-20250602","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/europace\/euab065","article-title":"2021 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"23","author":"Steffel","year":"2021","journal-title":"Europace"},{"key":"R48-20250602","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s10557-021-07170-6","article-title":"Proton pump inhibitor co-therapy in patients with atrial fibrillation treated with oral anticoagulants and a prior history of upper gastrointestinal tract bleeding","volume":"36","author":"Lee","year":"2022","journal-title":"Cardiovasc Drugs Ther"},{"key":"R49-20250602","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/CIRCULATIONAHA.122.062353","article-title":"Pharmacology and clinical development of factor XI inhibitors","volume":"147","author":"Greco","year":"2023","journal-title":"Circulation"},{"key":"R50-20250602","doi-asserted-by":"crossref","first-page":"e1038","DOI":"10.4244\/EIJ-D-22-00627","article-title":"Left atrial appendage occlusion","volume":"18","author":"Holmes","year":"2023","journal-title":"EuroIntervention"},{"key":"R51-20250602","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2021.10.023","article-title":"4-year outcomes after left atrial appendage closure versus nonwarfarin oral anticoagulation for atrial fibrillation","volume":"79","author":"Osmancik","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"R52-20250602","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N Engl J Med"},{"key":"R53-20250602","doi-asserted-by":"crossref","first-page":"e007414","DOI":"10.1161\/CIRCEP.119.007414","article-title":"Catheter ablation versus medical therapy for atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials","volume":"12","author":"Asad","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R54-20250602","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1001\/jamacardio.2021.0852","article-title":"Assessment of catheter ablation or antiarrhythmic drugs for first-line therapy of atrial fibrillation: a meta-analysis of randomized clinical trials","volume":"6","author":"Turagam","year":"2021","journal-title":"JAMA Cardiol"},{"key":"R55-20250602","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/jama.2019.0692","article-title":"Effect of catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation: the CABANA randomized clinical trial","volume":"321","author":"Mark","year":"2019","journal-title":"JAMA"},{"key":"R56-20250602","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N Engl J Med"},{"key":"R57-20250602","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2306037","article-title":"Catheter ablation in end-stage heart failure with atrial fibrillation","author":"Sohns","year":"2023","journal-title":"N Engl J Med"},{"key":"R58-20250602","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1001\/jama.2022.23722","article-title":"Effect of catheter ablation using pulmonary vein isolation with vs without posterior left atrial wall isolation on atrial arrhythmia recurrence in patients with persistent atrial fibrillation: the CAPLA randomized clinical trial","volume":"329","author":"Kistler","year":"2023","journal-title":"JAMA"},{"key":"R59-20250602","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.hrthm.2020.12.023","article-title":"Marshall bundle elimination, pulmonary vein isolation, and line completion for anatomical ablation of persistent atrial fibrillation (Marshall-PLAN): prospective, single-center study","volume":"18","author":"Derval","year":"2021","journal-title":"Heart Rhythm"},{"key":"R60-20250602","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa1602014","article-title":"Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation","volume":"374","author":"Kuck","year":"2016","journal-title":"N Engl J Med"},{"key":"R61-20250602","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/europace\/euab281","article-title":"Cryoballoon vs. radiofrequency catheter ablation: insights from NOrwegian randomized study of PERSistent Atrial Fibrillation (NO-PERSAF study)","volume":"24","author":"Shi","year":"2022","journal-title":"Europace"},{"key":"R62-20250602","first-page":"94","article-title":"Pulsed field ablation to treat atrial fibrillation: a review of the literature","volume":"9","author":"Di Monaco","year":"2022","journal-title":"J Cardiovasc Dev Dis"},{"key":"R63-20250602","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1161\/CIRCULATIONAHA.123.063988","article-title":"Pulsed field ablation for the treatment of atrial fibrillation: PULSED AF pivotal trial","volume":"147","author":"Verma","year":"2023","journal-title":"Circulation"},{"key":"R64-20250602","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1093\/europace\/euab150","article-title":"How does the level of pulmonary venous isolation compare between pulsed field ablation and thermal energy ablation (radiofrequency, cryo, or laser)?","volume":"23","author":"Kawamura","year":"2021","journal-title":"Europace"},{"key":"R65-20250602","doi-asserted-by":"crossref","first-page":"101","DOI":"10.31083\/j.rcm2303101","article-title":"Concomitant surgical ablation for treatment of atrial fibrillation in patients undergoing cardiac surgery","volume":"23","author":"Dominici","year":"2022","journal-title":"Rev Cardiovasc Med"},{"key":"R66-20250602","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1111\/jce.15113","article-title":"Efficacy of the stand-alone Cox-Maze IV procedure in patients with longstanding persistent atrial fibrillation","volume":"32","author":"McGilvray","year":"2021","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R67-20250602","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1093\/eurheartj\/ehaa658","article-title":"Catheter ablation vs. thoracoscopic surgical ablation in long-standing persistent atrial fibrillation: CASA-AF randomized controlled trial","volume":"41","author":"Haldar","year":"2020","journal-title":"Eur Heart J"},{"key":"R68-20250602","doi-asserted-by":"crossref","first-page":"e009288","DOI":"10.1161\/CIRCEP.120.009288","article-title":"Hybrid convergent procedure for the treatment of persistent and long-standing persistent atrial fibrillation: results of CONVERGE clinical trial","volume":"13","author":"DeLurgio","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R69-20250602","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMoa1001337","article-title":"Lenient versus strict rate control in patients with atrial fibrillation","volume":"362","author":"Van Gelder","year":"2010","journal-title":"N Engl J Med"},{"key":"R70-20250602","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1093\/eurheartj\/ehab569","article-title":"AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial","volume":"42","author":"Brignole","year":"2021","journal-title":"Eur Heart J"},{"key":"R71-20250602","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.jacc.2022.07.019","article-title":"Randomized trial of left bundle branch vs biventricular pacing for cardiac resynchronization therapy","volume":"80","author":"Wang","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"R72-20250602","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1817591","article-title":"Alcohol abstinence in drinkers with atrial fibrillation","volume":"382","author":"Voskoboinik","year":"2020","journal-title":"N Engl J Med"},{"key":"R73-20250602","doi-asserted-by":"crossref","first-page":"e009770","DOI":"10.1161\/CIRCEP.121.009770","article-title":"Alcohol consumption reduction and clinical outcomes of catheter ablation for atrial fibrillation","volume":"14","author":"Takahashi","year":"2021","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R74-20250602","first-page":"255","article-title":"The complex but fascinating relationship between sport and atrial fibrillation: from pathophysiology to the clinical scenario","volume":"10","author":"Tatangelo","year":"2023","journal-title":"J Cardiovasc Dev Dis"},{"key":"R75-20250602","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/eurheartj\/ehaa032","article-title":"Physical activity, cardiorespiratory fitness, and cardiovascular outcomes in individuals with atrial fibrillation: the HUNT study","volume":"41","author":"Garnvik","year":"2020","journal-title":"Eur Heart J"},{"key":"R76-20250602","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pcad.2023.04.010","article-title":"Obesity and atrial fibrillation: prevalence, pathogenesis, and prognosis","volume":"78","author":"Middeldorp","year":"2023","journal-title":"Prog Cardiovasc Dis"},{"key":"R77-20250602","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1161\/HYPERTENSIONAHA.120.14766","article-title":"Effect of intensive blood pressure lowering on the risk of atrial fibrillation","volume":"75","author":"Soliman","year":"2020","journal-title":"Hypertension"},{"key":"R78-20250602","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1093\/europace\/euac059","article-title":"Effects of intensive blood pressure control on cardiovascular and cognitive outcomes in patients with atrial fibrillation: insights from the SPRINT trial","volume":"24","author":"Jiang","year":"2022","journal-title":"Europace"},{"key":"R79-20250602","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jacc.2019.07.020","article-title":"Atrial fibrillation and diabetes mellitus: JACC review topic of the week","volume":"74","author":"Wang","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"R80-20250602","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1111\/dom.14772","article-title":"Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS program and CREDENCE trial and meta-analysis","volume":"24","author":"Li","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"R81-20250602","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.jacep.2022.08.004","article-title":"Efficacy of sodium-glucose cotransporter 2 inhibitors on outcomes after catheter ablation for atrial fibrillation","volume":"8","author":"Kishima","year":"2022","journal-title":"JACC Clin Electrophysiol"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000002906","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T19:01:41Z","timestamp":1748890901000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000002906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,1]]},"references-count":81,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000002906","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,1]]},"assertion":[{"value":"2023-07-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}